Polyone Stock Earnings Reports

Avient reported Q3 2025 adjusted EPS of $0.70, in line with guidance, driven by productivity, favorable mix (health care and defense) and margin expansion despite weaker-than-expected sales across consumer, packaging and several industrial end markets. Adjusted EBITDA margin expanded 60 basis points to 16.5% and year-to-date adjusted EPS grew 4.1% on flat sales. Management expects to realize approximately $40 million of productivity benefits in 2025 from sourcing, Lean Six Sigma, operations, footprint optimization and SG&A discipline. Outlook: organic sales are expected to be flat to down low single digits in Q4 (with potential for low-single-digit growth if certain defense orders or energy projects accelerate). The company narrowed its adjusted EBITDA full-year range to $540M–$550M but maintained its full-year adjusted EPS guidance of $2.77–$2.87, helped by lower interest expense and a third-quarter tax benefit. Avient plans ~$150M of debt reduction for the year (about $100M repaid YTD) and expects full-year capex of ~$110M and free cash flow of $190M–$210M. Management remains cautious on macro risks (trade policy, geopolitics, U.S. government shutdown, tariffs, interest rates) and is prepared to enact further productivity and organizational simplification if weak demand persists. Regional/segment notes: Consumer and packaging were notably weak (packaging especially in EMEA; consumer down double digits in Asia); SEM (Specialty Engineered Materials) outperformed with strong health care and defense growth; Latin America grew modestly and Asia showed pockets of strength, particularly where semiconductor-related packaging and local OEM demand exist.